+91-8668442535
Home / Biotechnology / Microbiome

Microbiome Sequencing Services Market By Research (Outsourced, In-house), By Technology (Shotgun, Targeted Gene, RNA And Whole Genome Sequencing, Others), By Application (Therapeutics, Genetic Screening, Drug and Biomarker Discovery, Personalized Medicine, Others), By End User (Pharmaceutical and Biotechnology Companies, Research and Academia Institutes, Others) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

The human body harbors around 100 trillion microbial organisms throughout the body, known as the microbiota, and the genomes of all the microflora are known as the microbiome. These microorganisms play a significant role in human health, including metabolism and immunity. Any alteration in the composition of the microbiome can lead to diseases such as ulcerative colitis, irritable bowel syndrome, Crohn's disease, psoriasis, asthma, and cardiovascular diseases. The study of gut microbes in diagnostics is a major focus, as changes in microbe types have been observed during inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.

Thus, microbiome sequencing helps in understanding a wide range of diseases and ailments and further treating them. There is a rise in funding for microbiome companies, start-ups, and research-based companies that amass knowledge and data for potential partnerships with pharmaceutical firms. With advancements in technology in genomics and microflora, microbiome-based therapeutics are evolving toward personalized medicine. Thus, potential growth is expected to be exhibited by the microbiome sequencing services market. Microbiome sequencing services have paved a new roadmap toward disease prevention and management.

The report titled "Microbiome Sequencing Services Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall microbiome sequencing services market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on the type of technology, application, research, end users, and different geographies. The technology types studied for analyzing the overall global microbiome sequencing services market are majorly segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and others.

The global microbiome sequencing services market is segmented by application type into therapeutics, genetic screening, drug and biomarker discovery, personalized medicine, and others. By research type, the global microbiome sequencing services market is segmented into outsourced and in-house. It is further segmented into end users: pharmaceutical and biotechnology companies, academia/research institutes, and others.

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year. This section also includes additional cross-sectional data on technology, application, research, end users, and constituent region or country-level markets.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges, and opportunities assists the reader in understanding the ongoing trends in the global microbiome sequencing services market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global microbiome sequencing services market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global microbiome sequencing services market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the vascular grafts market. The key players profiled in this report are Baseclear B.V., Clinical-Microbiomics A/S, Diversigen, Inc., Merieux Nutrisciences Corporation, Metabiomics Corp., Microbiome Therapeutics, LLC, Microbiome Insights, Inc., Molzym GmbH & Co. Kg., MR DNA (Molecular Research Lp), Openbiome, Shanghai Realbio Technology Co., Ltd., Rancho Biosciences, Resphera Biosciences, LLC, Ubiome, Inc., and Zymo Research Corp.

Based on the type of research, the global microbiome sequencing services market is segmented as follows:

  • Outsourced
  • In-house

The outsourced research segment dominates the global market for microbiome sequencing services. The large revenue share and highest CAGR of this segment are due to an increase in the outsourcing of research and development of drugs to CROs, especially in the Asia Pacific region. Emerging economies in the Asia Pacific region, such as China and India, are lucrative hubs for outsourcing. The in-house research segment is prominently observed among key market players with high investment and revenue growth. The housing segment shows moderate growth throughout the forecast period.

Based on the type of technology, the global microbiome sequencing services market is segmented as follows:

  • Shotgun Sequencing
  • Targeted gene sequencing
  • RNA Sequencing
  • Whole genome sequencing
  • Others 

Shotgun sequencing dominates the global microbiome sequencing services market. The shotgun sequencing method is fast and less expensive compared to other methods. The other advantage of this method is easy automation and scalability. Shotgun sequencing enables researchers to study all genes and microorganisms in a complex sample. It helps microbiologists evaluate diverse bacteria and detect the abundance of microbes in various environments. It is also able to study unculturable microorganisms that are not easy or sometimes impossible to analyze.

Based on the type of application, the global microbiome sequencing services market is segmented as follows:

  • Therapeutics
  • Oncology
  • Idiopathic Diseases
  • Infectious Diseases
  • Genetic Screening
  • Drug and biomarker discovery
  • Personalized Medicine
  • Others 

Human microbiome sequencing focuses on widespread research interest in treating a number of diseases. There is vigorous research and development on the association of microbiome alteration with diseases and the further study of the widespread network of interactions that affect the immune system, neurology, human metabolism, and skin. Microflora plays an important role in different areas of health, such as hygiene, infectious disease, and chronic health diseases. Dysbiosis in the gut is responsible for a wide range of conditions, such as irritable bowel syndrome, also known as Crohn's disease or ulcerative colitis, asthma, psoriasis, cancer, obesity, diabetes, neurological disorders, and even cardiovascular diseases.

Thus, therapeutic applications play a significant role in the microbiome market, occupying a major share and dominating the microbiome sequencing service market. The rise in the prevalence of cancer and infectious diseases is a major driving factor for the growth of the therapeutic segment in the microbiome sequencing service market. A rise in funding by the government and pharmaceutical companies in drug discovery and development and personalized medicine would exhibit fast growth in this segment of the microbiome sequencing service market.

Based on the type of end users, the global microbiome sequencing services market is segmented as follows:

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Others 

The pharmaceutical and biotechnology companies segment dominates the global microbiome sequencing services market and is anticipated to have the highest CAGR in the forecast period. There has been a significant rise in the funding of microbiome companies and start-ups. A similar rise is also observed in venture capital investment in microbiome companies, which has grown at a steady pace when compared with other areas of investment by venture capital firms. Thus, an increase in government funding or venture capitalist funding to boost research and development in drug discovery and development will, in turn, enhance the market for microbiome sequencing services.

For the purpose of this study, the global market for microbiome sequencing services is geographically categorized into:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest of Asia
  • Latin America
  • Brazil
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

In 2016, North America dominated the global microbiome sequencing services market, followed by Europe. In developed regions, high-throughput sequencing studies and new software tools are revolutionizing microbial analysis research. Major factors such as overall advancement in genome technology, a rise in government funding for genomics research, and the availability of next-generation sequencing for data analyses. Growing interested in microbiome sequencing for exploring personalized medicine and disease prevention and treatment is one of the key factors driving the growth of the microbiome sequencing services market, along with evolving sequencing technology.

Government and pharmaceutical company funding in research and development for drug discovery and development and genome screening and analysis plays an important role in boosting the growth of the microbiome sequencing services market in North America and Europe. Asia Pacific is anticipated to be the fastest-growing regional market in the forecast period of 2017–2025. The rise in the prevalence of diseases such as cancer and infectious disease, increasing investment in the development of healthcare, rising awareness about medical issues among the population, and evolving sequencing technology are some of the major reasons for the growth of the microbiome sequencing services market.

Frequently Asked Questions:

The market for Microbiome Sequencing Services Market is expected to reach US$ 2,519.3 Mn by 2025.

The Microbiome Sequencing Services Market is expected to see significant CAGR growth over the coming years, at 19.6%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Clinical-Microbiomics A/S, Diversigen, Inc., Merieux Nutrisciences Corporation, Metabiomics Corp., Microbiome Therapeutics, LLC, Microbiome Insights, Inc., Molzym GmbH & Co. Kg., MR DNA (Molecular Research Lp), Openbiome, Shanghai Realbio Technology Co., Ltd are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Aug 2017
Category:  Biotechnology
Report ID:   58642
Report Format:   PDF
Pages:   120
Rating:    4.5 (50)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support